Wenbin Mei, PhD

While much has been uncovered about the specific mutations that arise within a tumor, it is not fully understood how the DNA a person is born with (their inherited genetics) influences how those tumors grow. Dr. Mei’s research focuses on a specific, aggressive cancer gene called ERBB2, which is responsible for many breast, lung, and stomach cancers. Dr. Mei aims to discover if a patient’s inherited genetics makes them more likely to develop these specific tumor mutations or makes the cancer more dangerous. By understanding the interaction between a patient’s natural DNA and their tumor’s DNA, we can better predict cancer risks and find more effective, personalized treatments. Dr. Mei received his PhD from The Rockefeller University, New York, and his BS from Peking University, Beijing.